FOLH1 and cancer: While the rate of PSL among all cancers is unknown, the reported incidence among men with prostate cancer ranges from 0.1%, as described by a recently published paper by an Australian group that identified 5 men with prostate cancer using PSMA-avid PSL, to 0.5%, based on an older autopsy study21,22.